Beijing Science Sun Pharmaceutical Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Beijing Science Sun Pharmaceutical Co., Ltd. carries a market capitalization of 4.47B, placing it among publicly traded companies globally.
| Market Cap | 4.47B |
| Enterprise Value | N/A |
Share Statistics
Beijing Science Sun Pharmaceutical Co., Ltd. currently has 481.67M shares outstanding.
| Shares Outstanding | 481.67M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Beijing Science Sun Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 78.41. The price-to-sales ratio is 16.55, and the price-to-book ratio stands at 2.85.
| PE Ratio | 78.41 |
| PS Ratio | 16.55 |
| PB Ratio | 2.85 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | 73.64 |
| P/OCF Ratio | N/A |
Financial Position
Beijing Science Sun Pharmaceutical Co., Ltd. maintains a current ratio of 22.95, meaning it holds 22.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 22.95 |
| Quick Ratio | 21.18 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 3.70 |
| Return on Assets (ROA) | 2.37 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 3.96 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.51 |
Taxes
Over the trailing twelve months, Beijing Science Sun Pharmaceutical Co., Ltd. has paid 20.50M in income taxes, reflecting an effective tax rate of 21.00.
| Income Tax | 20.50M |
| Effective Tax Rate | 21.00 |
Stock Price Statistics
Beijing Science Sun Pharmaceutical Co., Ltd.'s stock has declined approximately -34.6723% over the past 52 weeks. The 50-day moving average sits at 9.55, while the 200-day moving average is 10.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | -34.6723% |
| 50-Day Moving Average | 9.55 |
| 200-Day Moving Average | 10.95 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Beijing Science Sun Pharmaceutical Co., Ltd. generated 398.45M in revenue and converted that into 84.08M in net income, yielding earnings per share of 0.16. EBITDA reached 20.95M, while operating income came in at 20.95M.
| Revenue | 398.45M |
| Gross Profit | 262.71M |
| Operating Income | 20.95M |
| Pretax Income | 97.65M |
| Net Income | 84.08M |
| EBITDA | 20.95M |
| EBIT | 20.95M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
Total book value stands at 2.31B, with working capital of 1.69B providing operational flexibility.
| Cash & Cash Equivalents | 1.63B |
| Total Debt | N/A |
| Net Debt | -76.61M |
| Equity (Book Value) | 2.31B |
| Book Value Per Share | 4.80 |
| Working Capital | 1.69B |
Cash Flow
After subtracting -89.52M in capital expenditures, free cash flow totaled -89.52M - equivalent to -0.19 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -89.52M |
| Free Cash Flow | -89.52M |
| FCF Per Share | -0.19 |
Margins
Beijing Science Sun Pharmaceutical Co., Ltd. operates with a gross margin of 65.93, reflecting its pricing power and cost economics. The operating margin of 5.26 and net profit margin of 21.10 provide insight into operational efficiency.
| Gross Margin | 65.93 |
| Operating Margin | 5.26 |
| Pretax Margin | 24.51 |
| Profit Margin | 21.10 |
| EBITDA Margin | 5.26 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.07 |
| FCF Yield | 1.36 |
Stock Splits
Beijing Science Sun Pharmaceutical Co., Ltd.'s most recent stock split took place on June 29, 2018 with a 1:2 split ratio.
| Last Split Date | 6/29/2018 |
| Split Ratio | 1:2 |
Scores
Beijing Science Sun Pharmaceutical Co., Ltd. posts an Altman Z-Score of 25.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 25.22 |